Breaking News Instant updates and real-time market news.

ABLX

Ablynx

$25.91

0.85 (3.39%)

, NVO

Novo Nordisk

$54.74

0.25 (0.46%)

08:50
01/08/18
01/08
08:50
01/08/18
08:50

Novo offer for Ablynx makes strategic sense, says Deutsche Bank

Deutsche Bank analyst Tim Race views Novo Nordisk's (NVO) acquisition offer for Ablynx (ABLX) as sensible, fitting with the stated company strategy and at a reasonable price. Depending on how discussions develop, the analyst would expect Novo to potentially raise its offer. Ablynx's caplacizumab could leverage Novo's readymade global haematology sales force with minimal additional cost, Race tells investors in a research note. The analyst keeps a Buy rating on Novo Nordisk.

ABLX

Ablynx

$25.91

0.85 (3.39%)

NVO

Novo Nordisk

$54.74

0.25 (0.46%)

  • 08

    Jan

  • 08

    Jan

ABLX Ablynx
$25.91

0.85 (3.39%)

11/20/17
BARD
11/20/17
INITIATION
Target $33
BARD
Outperform
Ablynx initiated with an Outperform at Baird
Baird analyst Brian Skorney initiated Ablynx with an Outperform rating, stating it has a host of promising internal assets for diseases with significant unmet needs and a proprietary platform technology. He sees the company well positioned over the next few years as it stands to receive significant milestone payments from big pharma partners. Skorney has a $33 price target on Ablynx shares.
11/20/17
LTCO
11/20/17
INITIATION
Target $30
LTCO
Buy
Ablynx initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Kevin DeGeeter started Ablynx with a Buy rating and $30 price target.
11/20/17
JEFF
11/20/17
NO CHANGE
Target $34
JEFF
Buy
Jefferies puts Buy rating, $34 target on Ablynx at Jefferies
Jefferies analyst Peter Welford says positive Phase III data further boost his belief that caplacizumab for rare blood disorder acquired thrombotic thrombocytopenic purpura is a "potential game-changer" for Ablynx. The analyst believes the drug may become a standard-of-care and he increased his approval probability to 90%. Welford believes caplacizumab's value is underappreciated at current share levels. He has a Buy rating on Ablynx's ADRs with a $34 price target.
11/20/17
11/20/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Innoviva (INVA) initiated with a Hold at Deutsche Bank. 2. National Vision (EYE) was initiated with an Overweight at Morgan Stanley, an Outperform at Wells Fargo, a Buy at Jefferies and Citi, as well as a Neutral at Goldman Sachs, UBS, and BofA/Merrill. 3. Ablynx (ABLX) was initiated with an Overweight at JPMorgan, an Outperform at Baird, and a Buy at Ladenburg. 4. Blue Apron (APRN) initiated with a Sector Weight at KeyBanc. 5. BP Midstream (BPMP) was initiated with an Overweight at JPMorgan, a Buy at UBS and Citi, an Equal Weight at Morgan Stanley and Barclays, as well as a Neutral at Goldman Sachs. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
NVO Novo Nordisk
$54.74

0.25 (0.46%)

12/01/17
MSCO
12/01/17
UPGRADE
MSCO
Overweight
Novo Nordisk upgraded to Overweight from Equal Weight at Morgan Stanley
12/06/17
BOFA
12/06/17
UPGRADE
BOFA
Buy
Novo Nordisk upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Sachin Jain upgraded Novo Nordisk to Buy citing high visible growth from the GLP-1 franchise and upward sentiment related to oral semaglutide data.
12/29/17
JPMS
12/29/17
UPGRADE
JPMS
Neutral
Novo Nordisk upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Richard Vosser upgraded Novo Nordisk to Neutral and raised his price target for the shares to 290 kroner from 230 kroner. The analyst expects "strong" oral semaglutide Phase III newsflow in 2018. He believes this will overshadow concerns over the long-term growth potential of the company's business.
12/29/17
12/29/17
NO CHANGE

On The Fly: Top five analyst actions
Catch up on today's top five analyst actions with this list compiled by The Fly: 1. AstraZeneca (AZN) upgraded to Overweight from Neutral at JPMorgan with analyst James Gordon saying the company's "superior medium-term growth outlook," which is twice the peer average, warrants a 25% sector premium. 2. PriceSmart (PSMT) upgraded to Outperform from Market Perform at IFS Securities. 3. Novo Nordisk (NVO) upgraded to Neutral from Underweight at JPMorgan with analyst Richard Vosser saying he expects "strong" oral semaglutide Phase III newsflow in 2018. 4. Syntel (SYNT) downgraded to Underperform from Market Perform at Wells Fargo with analyst Ed Caso saying he sees the company's "weak" positioning for the ongoing shift in information technology demand from "legacy" low-cost offshore-centric software services to more onshore-necessary "digital" solutions as dragging down its growth and margins. 5. RioCan REIT downgraded to Sector Perform from Outperform at RBC Capital. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ZSAN

Zosano Pharma

$0.47

0.0164 (3.64%)

10:55
01/23/18
01/23
10:55
01/23/18
10:55
Conference/Events
Zosano Pharma to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

OSTK

Overstock.com

$77.40

-0.25 (-0.32%)

10:50
01/23/18
01/23
10:50
01/23/18
10:50
Periodicals
Overstock ICO promotion 'false and misleading,' Medium contributor says »

A contributor to Medium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRP

Ctrip.com

$46.14

-0.71 (-1.52%)

10:50
01/23/18
01/23
10:50
01/23/18
10:50
Options
Short-term put buyers in Ctrip as shares stumble »

Short-term put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBLN

Obalon Therapeutics

$5.19

-0.05 (-0.95%)

10:46
01/23/18
01/23
10:46
01/23/18
10:46
Hot Stocks
Obalon Therapeutics terminates stock offering after whistleblower allegations »

Obalon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

TFX

Teleflex

$274.20

-0.55 (-0.20%)

10:44
01/23/18
01/23
10:44
01/23/18
10:44
Conference/Events
Leerink medical devices analysts hold an analyst/industry conference call »

Medical Devices Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

  • 28

    Feb

  • 01

    Mar

TWTR

Twitter

$22.73

-0.5928 (-2.54%)

10:42
01/23/18
01/23
10:42
01/23/18
10:42
Recommendations
Twitter analyst commentary  »

Twitter data points to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

ILG

ILG

$29.45

-0.03 (-0.10%)

10:40
01/23/18
01/23
10:40
01/23/18
10:40
Options
Repeat interest in ILG Mar 30 calls »

Repeat interest in ILG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
01/23/18
01/23
10:35
01/23/18
10:35
Conference/Events
Morgan Stanley technology analyst holds an analyst/industry conference call »

Technology/Hardware…

ABEO

Abeona Therapeutics

$14.85

0.25 (1.71%)

, JKHY

Jack Henry

$125.32

0.17 (0.14%)

10:31
01/23/18
01/23
10:31
01/23/18
10:31
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

ABEO

Abeona Therapeutics

$14.85

0.25 (1.71%)

JKHY

Jack Henry

$125.32

0.17 (0.14%)

WWD

Woodward

$81.02

0.52 (0.65%)

NAV

Navistar

$44.96

0.21 (0.47%)

GBT

Global Blood Therapeutics

$56.35

2.4 (4.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

NFLX

Netflix

$227.58

7.12 (3.23%)

, GPRO

GoPro

$6.30

0.01 (0.16%)

10:31
01/23/18
01/23
10:31
01/23/18
10:31
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

NFLX

Netflix

$227.58

7.12 (3.23%)

GPRO

GoPro

$6.30

0.01 (0.16%)

W

Wayfair

$88.60

-2.04 (-2.25%)

FTNT

Fortinet

$45.85

-0.16 (-0.35%)

S

Sprint

$5.23

-0.091 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 01

    Feb

  • 02

    Feb

  • 05

    Feb

  • 22

    Feb

DG

Dollar General

$103.69

1.424 (1.39%)

, DKS

Dick's Sporting

$34.91

0.29 (0.84%)

10:31
01/23/18
01/23
10:31
01/23/18
10:31
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

DG

Dollar General

$103.69

1.424 (1.39%)

DKS

Dick's Sporting

$34.91

0.29 (0.84%)

CAT

Caterpillar

$170.43

-0.46 (-0.27%)

RMD

ResMed

$101.77

14.26 (16.30%)

HPE

HP Enterprise

$16.37

0.315 (1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

SBUX

Starbucks

$61.41

0.15 (0.24%)

10:30
01/23/18
01/23
10:30
01/23/18
10:30
Options
Starbucks calls drawing interest ahead of earnings »

Starbucks calls drawing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

KMB

Kimberly-Clark

$117.35

0.4358 (0.37%)

10:29
01/23/18
01/23
10:29
01/23/18
10:29
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

KMI

Kinder Morgan

$19.45

-0.18 (-0.92%)

10:28
01/23/18
01/23
10:28
01/23/18
10:28
Hot Stocks
Kinder Morgan begins operations of Utopia Pipeline system »

Kinder Morgan announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$117.26

0.35 (0.30%)

10:27
01/23/18
01/23
10:27
01/23/18
10:27
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark: China…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

PFIE

Profire Energy

$2.01

0.03 (1.52%)

10:26
01/23/18
01/23
10:26
01/23/18
10:26
Conference/Events
Profire Energy management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

NFLX

Netflix

$227.58

7.12 (3.23%)

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
Netflix management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

MLHR

Herman Miller

$40.95

0.4 (0.99%)

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
Herman Miller management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 30

    Jan

  • 31

    Jan

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
RBC Capital software analysts hold an analyst/industry conference call »

Software Analysts…

RARE

Ultragenyx

$53.39

4.23 (8.60%)

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
Ultragenyx participates in a conference call with JPMorgan »

Investor conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 17

    Apr

  • 24

    Jan

LLEX

Lilis Energy

$4.86

-0.14 (-2.80%)

10:24
01/23/18
01/23
10:24
01/23/18
10:24
Conference/Events
Lilis Energy management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 31

    Jan

EBAY

eBay

$39.58

1.15 (2.99%)

, GOOG

Alphabet

$1,155.81

18.3 (1.61%)

10:21
01/23/18
01/23
10:21
01/23/18
10:21
Periodicals
eBay CEO says shoppers are shifting to voice technology, CNBC reports »

eBay (EBAY) CEO Devin…

EBAY

eBay

$39.58

1.15 (2.99%)

GOOG

Alphabet

$1,155.81

18.3 (1.61%)

GOOGL

Alphabet Class A

$1,164.16

20.66 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

CMD

Cantel Medical

$112.00

0.7 (0.63%)

10:21
01/23/18
01/23
10:21
01/23/18
10:21
Conference/Events
Cantel Medical management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 31

    Jan

KMB

Kimberly-Clark

$116.87

-0.04 (-0.03%)

10:20
01/23/18
01/23
10:20
01/23/18
10:20
Hot Stocks
Kimberly-Clark sees 2H18 EPS higher than 1H18 »

On its Q4 earnings call,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

10:20
01/23/18
01/23
10:20
01/23/18
10:20
General news
Nasdaq leads major averages as Netflix jumps after earnings »

Stock futures were little…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.